Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction-Reference-Cited by-同舟云学术

Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction

Published:2021-01 Issue:3 Volume:77 Page:243-255
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Santos-Gallego Carlos G.,Vargas-Delgado Ariana P.,Requena-Ibanez Juan Antonio,Garcia-Ropero Alvaro,Mancini Donna,Pinney Sean,Macaluso Frank,Sartori Samantha,Roque Merce,Sabatel-Perez Fernando,Rodriguez-Cordero Anderly,Zafar M. Urooj,Fergus Icilma,Atallah-Lajam Farah,Contreras Johanna P.,Varley Cathleen,Moreno Pedro R.,Abascal Vivian M.,Lala Anuradha,Tamler Ronald,Sanz Javier,Fuster Valentin,Badimon Juan J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference43 articles.

1. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015

2. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N Engl J Med,2017

3. Dapagliflozin and cardiovascular outcomes in type 2 diabetes;Wiviott;N Engl J Med,2019

4. Dapagliflozin in patients with heart failure and reduced ejection fraction;McMurray;N Engl J Med,2019

5. Cardiovascular and renal outcomes with empagliflozin in heart failure;Packer;N Engl J Med,2020

Cited by 324 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haemodynamic Effects of Sodium–Glucose Cotransporter 2 Inhibitor Treatment in Chronic Heart Failure Patients;Cardiac Failure Review;2024-09-11

2. Association between sodium-glucose cotransporter 2 inhibitors and eye disorders: a systematic review and meta-analysis;Expert Review of Clinical Pharmacology;2024-09-11

3. Looking for the ideal medication for heart failure with reduced ejection fraction: a narrative review;Frontiers in Cardiovascular Medicine;2024-09-06

4. Clinical Update in Heart Failure with Preserved Ejection Fraction;Current Heart Failure Reports;2024-09-03

5. Evaluation of Cardiac Function Outcomes in Non-Diabetic Heart Failure Patients Treated with SGLT2 Inhibitors;Journal of Korean Society of Health-System Pharmacists;2024-08-31